NCT05029284Completed
Behavioral Activation for Post-Stroke Sedentary Behavior Using Telehealth
teleABLE: Adapting a Behavioral Activation-Based Intervention to Reduce Post-Stroke Sedentary Behavior Using Telehealth (Formative Phase)
Source: ClinicalTrials.gov · Last updated 29 Jun 2025
Brief summary (registry, in English)
Adults with stroke-related disability spend more time sedentary than adults without stroke-related disability, which places them at risk for poor cardiovascular health outcomes. Few interventions are designed to reduce post-stroke sedentary time. The purpose of this research is to test whether the teleABLE (Activating Behavior for Lasting Engagement) Intervention is feasible and acceptable to adults within the first 12 months post-stroke. The hypothesis is that teleABLE can be feasibly delivered using videoconferencing within the first 12 months post-stroke. 10 participants will complete assessments and activity monitoring (activPAL micro3) at 0 (baseline) and 8 (post-intervention)-weeks. Participants will complete 12 sessions of the teleABLE intervention. Findings from this study will be used to guide the intervention protocol in the planned next phase of this research.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 11 (actual)
- First submitted
- 30 Jul 2021
- Start date
- 20 Dec 2021
- Primary completion date
- 18 Mar 2024
- Lead sponsor
- University of Minnesota
- Diseases
- Stroke
- NCT number
- NCT05029284
What you commit to
- Study type: Interventional
- Participants enrolled: 11
- From 20 Dec 2021 to the primary completion date, 18 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently receiving care in an inpatient rehabilitation, transitional care unit, or skilled nursing facility
- Received inpatient treatment or hospitalized for psychiatric condition and/or alcohol or substance abuse within the past 12 months
- Concurrent participation in another rehabilitation intervention research study
Other illness
- Comorbid neurodegenerative disorder (e.g. Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, myasthenia gravis, dementia, Alzheimer's disease, Huntington's disease, glioblastoma)
- Comorbid cancer, currently undergoing chemotherapy or radiation treatment
- Comorbid major depressive disorder (assessed by Patient Health Questionnaire-2, score ≥2)
- Diagnosis of a terminal illness and/or in hospice care
- History of skin sensitivity that precludes the use of medical tape necessary for adherence to activity monitor measure
Other
- Severe cognitive or communication impairments (inability to respond accurately to complete study telephone screening or complete informed consent)
- Inability to speak, read, or understand English
- Investigator discretion for safety or adherence reasons
Who the study is looking for
- Stroke diagnosis ≤12 months prior to study enrollment
- ≥6 hours of sedentary behavior on a typical weekday (assessed by Sedentary Behavior Questionnaire)
- Ambulatory with or without assistive device (assessed by Functional Independence Measure, mobility score ≥5)
- Able to access an electronic device (smartphone, tablet, or computer) that is compatible with a videoconferencing application
- Able to identify a support person with whom the participant has face-to-face interaction at least one time per week
- Able and willing to participate fully in the study and provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.